Burning Rock Biotech Ltd (BNR)
8.03
-0.20
(-2.43%)
USD |
NASDAQ |
May 16, 16:00
8.20
+0.17
(+2.12%)
After-Hours: 20:00
Burning Rock Biotech Profit Margin (Quarterly): -134.0% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -134.0% |
| September 30, 2023 | -137.2% |
| June 30, 2023 | -89.73% |
| March 31, 2023 | -130.0% |
| December 31, 2022 | -152.0% |
| September 30, 2022 | -149.7% |
| June 30, 2022 | -200.3% |
| March 31, 2022 | -192.9% |
| December 31, 2021 | -170.4% |
| September 30, 2021 | -134.6% |
| Date | Value |
|---|---|
| June 30, 2021 | -160.0% |
| March 31, 2021 | -160.8% |
| December 31, 2020 | -118.8% |
| September 30, 2020 | -102.6% |
| June 30, 2020 | -66.42% |
| March 31, 2020 | -78.08% |
| December 31, 2019 | -107.2% |
| September 30, 2019 | -31.01% |
| June 30, 2019 | -30.69% |
| March 31, 2019 | -15.19% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-200.3%
Minimum
Jun 2022
-30.69%
Maximum
Jun 2019
-123.5%
Average
-134.0%
Median
Dec 2023
Profit Margin (Quarterly) Benchmarks
| Sinovac Biotech Ltd | -- |
| CASI Pharmaceuticals Inc | -88.09% |
| Zai Lab Ltd | -61.36% |
| Gracell Biotechnologies Inc (DELISTED) | -- |
| Adagene Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -68.03% |
| Return on Assets | -49.94% |
| Return on Invested Capital | -68.03% |
| Gross Profit Margin (Quarterly) | 64.51% |
| Operating Margin (Quarterly) | -137.4% |
| Return on Net Operating Assets | -126.6% |